Applications

1272 – Transurethral Injection of Botulinum Toxin (Botox) into the Bladder Wall for Urinary Incontinence due to Idiopathic Overactive Bladder

Find out about the service or technology in this application and the medical condition it addresses. You can also view the application documents, the deadlines for providing consultation input and the outcome of the application when the MSAC process is complete.

  • Status Complete
  • Type New application
  • Pre-PASC consultation -
  • Pre-MSAC consultation -
  • Outcome Supported

Application details

Reason for application

-

Service or technology in this application

Transurethral injection of Botox into the inner bladder wall, guided by cystoscopy for the treatment of urinary incontinence.

Medical condition this application addresses

Diopathic overactive bladder with urinary incontinence

Overactive bladder is caused by a dysfunction in the coordinated mechanisms that provide controlled storage and voiding of urine. This can lead to sudden urges to urinate, which may be difficult to suppress, leading to the involuntary loss of urine (incontinence). Bladder overactivity is also associated with increased pressure within the bladder, which can lead to upper urinary tract complications and renal damage. For idiopathic overactive bladder, the cause of bladder dysfunction is unknown.

Meetings to consider this application

  • PASC meeting: 
    • 16 - 17 August 2012
    • 13 - 14 December 2012
  • ESC meeting: -
  • MSAC meeting:
    • 28 November 2013
    • 27 July 2017